The Role of Secondary Lesion Biopsy in Detecting Clinically Significant Prostate Cancer

Documenti analoghi

• Impact of Testosterone Recovery on Oncologic Outcomes in High‐Risk, Localized Prostate Cancer
  di: Trevor C. Hunt, et al.
  Pubblicazione: (2025)
• Outcome Differences Between Subgroups of Favorable Intermediate Risk Prostate Cancer After Radical Prostatectomy
  di: Matthew T. Steidle, et al.
  Pubblicazione: (2026)
• Long‐Term Oncological Outcomes of Robot‐Assisted Radical Prostatectomy for Clinically Localized Grade Groups 4 and 5 Prostate Cancers Diagnosed on Prostate Biopsy
  di: Victor Sandoval, et al.
  Pubblicazione: (2025)
• Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy
  di: Yuto Ono, et al.
  Pubblicazione: (2025)
• Comparative Evaluation of Detection Rates for Clinically Significant Prostate Cancer Using MRI‐Targeted Biopsy Alone Versus in Combination With Systematic Biopsies: Development of a Risk‐Stratification Scoring System
  di: Toshifumi Takahashi, et al.
  Pubblicazione: (2024)